[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100300655":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":38,"collaborators":40,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":7,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":7,"maxAge":7,"enrollmentInfo":72,"targetDuration":75,"studyType":76,"phases":7,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":16,"whyStopped":7,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Peking Union Medical College Hospital","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Kai-Feng Xu, M.D.","CONTACT","86-10-69155039","xukf@pumch.cn",[15],{"facility":5,"status":16,"city":17,"state":18,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"RECRUITING","Beijing","Beijing Municipality","100730","China","CN",{"type":23,"coordinates":24},"Point",[25,26],116.39723,39.9075,{"lat":26,"lon":25},[29,30,33,36],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":31,"role":11,"phone":12,"phoneExt":7,"email":32},"XinLun Tian, M.D.","xinlun_t@sina.com",{"name":34,"role":35,"phone":7,"phoneExt":7,"email":7},"Xinlun Tian, M.D.","SUB_INVESTIGATOR",{"name":10,"role":37,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[41,43,45,47,50,52,54,56,58,60,62],{"name":42,"class":6},"Shanghai Zhongshan Hospital",{"name":44,"class":6},"Guangzhou Institute of Respiratory Disease",{"name":46,"class":6},"Central South University",{"name":48,"class":49},"Anhui Provincial Hospital","OTHER_GOV",{"name":51,"class":6},"Xiangya Hospital of Central South University",{"name":53,"class":6},"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",{"name":55,"class":6},"Wuxi People's Hospital",{"name":57,"class":6},"Beijing Shijitan Hospital, Capital Medical University",{"name":59,"class":6},"West China Hospital",{"name":61,"class":6},"Fujian Provincial Hospital",{"name":63,"class":6},"Wuhan TongJi Hospital","100300655","a-national-registry-on-chinese-patients-with-lymphangioleiomyomatosis-100300655",false,"NCT03193892","A National Registry on Chinese Patients With Lymphangioleiomyomatosis","A National Registry on Clinical Manifestations, Genetics, Interventions, and Outcomes in Chinese Patients With Lymphangioleiomyomatosis (LAM-CHINA)","Inclusion Criteria:\n\n1. Gender: female.\n2. Age: no limitation.\n3. Diagnosis meets one of the following criteria, (1) definite or probable diagnosis of LAM based on ATS\u002FJRS and ERS criteria. (2) Investigators recommend including of the patient.\n\nExclusion Criteria:\n\n1. Suspected LAM patients without other supporting evidence for LAM diagnosis.\n2. No diffuse cystic lesions in the lung.\n3. Patients with bilateral cystic lung lesions but the LAM diagnosis cannot be established.\n4. Without signed informed consent.\n5. Difficult to follow up.","FEMALE",{"count":73,"type":74},1500,"ESTIMATED","10 Years","OBSERVATIONAL","Pulmonary lymphangioleiomyomatosis (LAM), a disease characterized by diffuse cystic changes in the lung, is a rare disorder that affects almost exclusively women. The main objectives of this study are to accurately evaluate the prevalence of LAM, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.",[79],"Pulmonary Function",[81,20,82],"registry","lymphangioleiomyomatosis","2021-09-18",{"date":85,"type":86},"2021-09-24","ACTUAL",{"date":88,"type":86},"2017-01-01",{"date":90,"type":74},"2026-10-01",{"name":5,"class":6},1]